Clinical Trial Update: Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating TGW101 in adults with advanced solid tumors is recruiting to assess safety, tolerability, pharmacokinetics, and preliminary efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• TGW101

Snippet

Sponsor: Tagworks Pharmaceuticals BV | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING